Vast Therapeutics
company
About
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .
- Durham,North Carolina,United States
- 1 - 10
- http://vasttherapeutics.com/
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.20M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- Novoclem
Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the preclinical stage of developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$16.20M
Vast Therapeutics has raised a total of
$16.20M
in funding over 2 rounds. Their latest funding was raised on
Nov 8, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 8, 2022 | Grant | $1.20M | 1 |
Collaboratory
|
— | Detail |
| Jan 15, 2019 | Series A | $15M | 2 |
Shionogi
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Vast Therapeutics is funded by 3 investors.
Collaboratory
and Shionogi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Collaboratory
|
Yes | Grant |
|
Shionogi
|
Yes | Series A |
Cystic Fibrosis Foundation
|
— | Series A |
Employee Profiles
Number of Employee Profiles
4
Vast Therapeutics has 4 current employee profiles, including
Executive F. Neal Hunter
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
